A study in Chinese HIV-1 isolates found that the Geno2pheno algorithm frequently overestimates CXCR4 tropism for the CRF01_AE subtype, raising concerns about relying solely on genotype-based inference for treatment decisions. The finding points to the need for phenotypic validation when selecting regimens influenced by tropism. For clinical teams, the implication is practical: inaccurate tropism assignment can affect which drugs are appropriate, particularly when therapy choices depend on whether the virus uses CXCR4 coreceptors versus CCR5. The report frames Geno2pheno overestimation as a frequent issue in this population, suggesting local laboratory validation steps should be considered when genotype tools are imported into guideline workflows for CRF01_AE.